38
Views
19
CrossRef citations to date
0
Altmetric
Guidelines for Prevention and Treatment of Infection in Orthopedic Prosthetic Surgery

Two-Stage Exchange Hip Arthroplasty for Deep Infection

References

  • Hill C, Flamant R, Mazas F, Evrard J. Prophylactic cefa-zolin versus placebo in total hip replacement. Report of a mul-ticentre double-blind randomised trial. Lancet 1981; 1 (8224): 795–796.
  • Lidwell OM, Lowbury EJ, Whyte W, Blowers R, Stanley SJ, Lowe D. Effect of ultraclean air in operating rooms on deep sepsis in the joint after total hip or knee replacement: a randomised study. Br Med J (Clin Res Ed) 1982; 285 (6334): 10–14.
  • Salvati EA, Callaghan JJ, Brause BD, Klein RF, Small RD. Reimplantation in infection. Elution of gentamicin from cement and beads. Clin Orthop 1986; 207: 83–93.
  • Schmalzried TP, Amstutz HC, Au MK, Dorey FJ. Etiology of deep sepsis in total hip arthroplasty. The signifi-cance of hematogenous and recurrent infections. Clin Orthop 1992; 280: 200–207.
  • Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hun-dred and six infections. J Bone Joint Surg Am 1996; 78 (4): 512–523.
  • Sculco TP. The economic impact of infected total joint arthroplasty. Instr Course Lect 1993; 42: 349–351.
  • Deacon JM, Pagliaro AJ, Zelicof SB, Horowitz HW. Prophylactic use of antibiotics for procedures after total joint replacement [see comments]. J Bone Joint Surg Am 1996; 78 (11): 1755–1770.
  • Fitzgerald RHJ. Infected Total Hip Arthroplasty: Diagnosis and Treatment. J Am Acad Orthop Surg 1995; 3 (5): 249–262.
  • Garvin KL, Fitzgerald RHJ, Salvati EA, et al. Reconstruction of the infected total hip and knee arthroplasty with gentamicin-impregnated Palacos bone cement. Instr Course Lect 1993; 42: 293–302.
  • Hirakawa K, Stulberg BN, Wilde AH, Bauer TW, Secic M. Results of 2-stage reimplantation for infected total knee arthroplasty. J Arthroplasty 1998; 13 (1): 22–28.
  • James PJ, Butcher IA, Gardner ER, Hamblen DL. Methicillin-resistant Staphylococcus epidermidis in infection of hip arthroplasties. J Bone Joint Surg Br 1994; 76 (5): 725–727.
  • Garvin KL, Hinrichs SH, Urban JA. Emerging antibiot-ic-resistant bacteria. Their treatment in total joint arthroplasty. Clin Orthop 1999; 369: 110–123.
  • Centers for Disease Control: National nosocomial infec-tion surveillance (NNIS) system. Rate of vancomycin-resistant enterococci, by intensive care unit status. MMWR Morb Mortal Wkly Rep 1993; 42: 597–599.
  • Spangehl MJ, Younger AS, Masri BA, Duncan CP. Diagnosis of infection following total hip arthroplasty. Instr Course Lect 1998; 47: 285–295.
  • Hughes PW, Salvati EA, Wilson PDJ, Blumenfeld EL. Treatment of subacute sepsis of the hip by antibiotics and joint replacement. Criteria for diagnosis with evaluation of twenty-six cases. Clin Orthop 1979; 141: 143–157.
  • Fehring TK, Cohen B. Aspiration as a guide to sepsis in revision total hip arthroplasty. J Arthroplasty 1996; 11 (5): 543–547.
  • Mulcahy DM, Fenelon GC, McInerney DP. Aspiration arthrography of the hip joint. Its uses and limitations in revi-sion hip surgery. J Arthroplasty 1996; 11 (1): 64–68.
  • Mirra JM, Amstutz HC, Matos M, Gold R. The patholo-gy of the joint tissues and its clinical relevance in prosthesis failure. Clin Orthop 1976; 117: 221–240.
  • Athanasou NA, Pandey R, de Steiger R, Crook D, Smith PM. Diagnosis of infection by frozen section during revision arthroplasty. J Bone Joint Surg Br 1995; 77 (1): 28–33.
  • Lonner JH, Desai P, Dicesare PE, Steiner G, Zuckerman JD. The reliability of analysis of intraoperative frozen sections for identifying active infection during revision hip or knee arthroplasty. J Bone Joint Surg Am 1996; 78 (10): 1553–1558.
  • Murray WR. Results in patients with total hip replace-ment arthroplasty. Clin Orthop 1973; 95: 80–90.
  • Tietjen R, Stinchfield FE, Michelsen CB. The signifi-cance of intracapsular cultures in total hip operations. Surg Gynecol Obstet 1977; 144 (5): 699–702.
  • Tunney MM, Patrick S, Gorman SP, et al. Improved detection of infection in hip replacements. A currently under-estimated problem. J Bone Joint Surg Br 1998; 80 (4): 568–572.
  • Tunney MM, Patrick S, Curran MD, et al. Detection of prosthetic hip infection at revision arthroplasty by immunoflu-orescence microscopy and PCR amplification of the bacterial 16S rRNA gene. J Clin Microbiol 1999; 37 (10): 3281–3290.
  • Mariani BD, Martin DS, Levine MJ, Booth REJ, Tuan RS. The Coventry Award. Polymerase chain reaction detec-tion of bacterial infection in total knee arthroplasty. Clin Orthop 1996; 331: 11–22.
  • Hoeffel DP, Hinrichs SH, Garvin KL. Molecular diag-nostics for the detection of musculoskeletal infection. Clin Orthop 1999; 360: 37–46.
  • Canvin JM, Goutcher SC, Hagig M, Gemmell CG, Sturrock RD. Persistence of Staphylococcus aureus as detect-ed by polymerase chain reaction in the synovial fluid of a patient with septic arthritis. Br J Rheumatol 1997; 36 (2): 203–206.
  • Rapley R, Theophilus BD, Bevan IS, Walker MR. Fundamentals of the polymerase chain reaction: a future in clinical diagnostics? Med Lab Sci 1992; 49 (2): 119–128.
  • Gristina AG, Kolkin J. Current concepts review. Total joint replacement and sepsis. J Bone Joint Surg [Am] 1983; 65 (1): 128–134.
  • Stoll T, Stucki G, Bruhlmann P, Vogt M, Gschwend N, Michel BA. Infection of a total knee joint prosthesis by Pep-tostreptococcus micros and Propionibacterium acnes in an elderly RA patient: implant salvage with longterm antibiotics and needle aspiration/irrigation. Clin Rheumatol 1996; 15 (4): 399–402.
  • Fitzgerald RHJ, Nolan DR, Ilstrup DM, Van Scoy RE, Washington JA, Coventry MB. Deep wound sepsis following total hip arthroplasty. J Bone Joint Surg [Am] 1977; 59 (7): 847–855.
  • Coventry MB. Treatment of infections occurring in total hip surgery. Orthop Clin North Am 1975; 6 (4): 991–1003.
  • Estrada R, Tsukayama D, Gustilo R. Management of THA infections, a prospective study of 108 cases. Orthop Trans 1993; 17: 1114-1115.
  • Crockarell JR, Hanssen AD, Osmon DR, Morrey BF. Treatment of infection with debridement and retention of the components following hip arthroplasty. J Bone Joint Surg Am 1998; 80 (9): 1306–1313.
  • Buchholz HW, Elson RA, Engelbrecht E, Lodenkamper H, Rottger J, Siegel A. Management of deep infection of total hip replacement. J Bone Joint Surg [Br] 1981; 63-B (3): 342-353.
  • Raut VV, Siney PD, Wroblewski BM. One-stage revi-sion of total hip arthroplasty for deep infection. Long-term fol-lowup. Clin Orthop 1995; 321: 202–207.
  • Ure KJ, Amstutz HC, Nasser S, Schmalzried TP. Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am 1998; 80 (7): 961–968.
  • Murray WR. Use of antibiotic-containing bone cement. Clin Orthop 1984; 190: 89–95.
  • Nelson JP. Deep infection following total hip arthro-plasty. J Bone Joint Surg [Am] 1977; 59 (8): 1042–1044.
  • Grauer JD, Amstutz HC, O'Carroll PF, Dorey FJ. Resection arthroplasty of the hip. J Bone Joint Surg [Am] 1989; 71 (5): 669–678.
  • McElwaine JP, Colville J. Excision arthroplasty for infected total hip replacements. J Bone Joint Surg [Br] 1984; 66 (2): 168–171.
  • Garvin KL, Evans BC, Salvati EA, Brause BD. Palacos gentamicin for the treatment of deep periprosthetic hip infec-tions. Clin Orthop 1994; 298: 97–105.
  • Lieberman JR, Callaway CH, Salvati EA, Pellicci PM, Brause BD. Treatment of the infected total hip arthroplasty with a two-stage reimplantation protocol. Clin Orthop 1994; 301: 205–212.
  • McDonald DJ, Fitzgerald RHJ, Ilstrup DM. Two-stage reconstruction of a total hip arthroplasty because of infection. J Bone Joint Surg [Am] 1989; 71 (6): 828–834.
  • Haddad FS, Muirhead-Allwood SK, Manktelow AR, Bacarese-Hamilton I. Two-stage uncemented revision hip arthroplasty for infection. J Bone Joint Surg Br 2000; 82 (5): 689–694.
  • Younger AS, Duncan CP, Masri BA, McGraw RW. The outcome of two-stage arthroplasty using a custom-made inter-val spacer to treat the infected hip. J Arthroplasty 1997; 12 (6): 615–623.
  • Callaghan JJ, Katz RP, Johnston RC. One-stage revi-sion surgery of the infected hip. A minimum 10-year followup study. Clin Orthop 1999; 369: 139–143.
  • Katz RP, Callaghan JJ, Johnston RC, Katz RP, Callaghan JJ, Johnston RC. A minimum ten year follow-up study of one stage reimplantation of the infected total hip. Orthop Trans 1994; 18: 993.
  • Miley GB, Scheller ADJ, Turner RH. Medical and surgi-cal treatment of the septic hip with one-stage revision arthro-plasty. Clin Orthop 1982; 170: 76–82.
  • Raut VV, Siney PD, Wroblewski BM. One-stage revi-sion of infected total hip replacements with discharging sinus-es. J Bone Joint Surg Br 1994; 76 (5): 721–724.
  • Wroblewski BM. One-stage revision of infected cement-ed total hip arthroplasty. Clin Orthop 1986; 211: 103–107.
  • Jackson WO, Schmalzried TP. Limited role of direct exchange arthroplasty in the treatment of infected total hip replacements.[In Process Citation]. Clin Orthop 2000; 381: 101–105.
  • Masterson EL, Masri BA, Duncan CP. Treatment of infection at the site of total hip replacement. Instr Course Lect 1998; 47: 297–306.
  • Haddad FS, Masri BA, Garbuz DS, Duncan CP. The treatment of the infected hip replacement. The complex case. Clin Orthop 1999; 369: 144–156.
  • Berry DJ, Chandler HP, Reilly DT. The use of bone allografts in two-stage reconstruction after failure of hip replacements due to infection. J Bone Joint Surg [Am] 1991; 73 (10): 1460–1468.
  • Gustilo RB, Pasternak HS. Revision total hip arthroplas-ty with titanium ingrowth prosthesis and bone grafting for failed cemented femoral component loosening. Clin Orthop 1988; 235: 111–119.
  • Gustilo RB, Tsukayama D. Treatment of infected cemented total hip arthroplasty with tobramycin beads and delayed revision with a cementless prosthesis and bone graft-ing. Orthop Trans 1988; 12 739.
  • Lai KA, Yang CY, Lin RM, Jou IM, Lin CJ. Cementless reimplantation of hydroxyapatite-coated total hips after periprosthetic infections. J Formos Med Assoc 1996; 95 (6): 452–457.
  • Nestor BJ, Hanssen AD, Ferrer-Gonzalez R, Fitzgerald RHJ. The use of porous prostheses in delayed reconstruction of total hip replacements that have failed because of infection. J Bone Joint Surg Am 1994; 76 (3): 349–359.
  • Garvin KL, Hanssen AD. Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg Am 1995; 77 (10): 1576–1588.
  • Carllson AS, Josefsson G, Lindberg L. Revision with gentamicin-impregnated cement for deep infections in total hip arthroplasties. J Bone Joint Surg [Am] 1978; 64: 1059–1064.
  • Murray WR. Treatment of established deep wound infection after hip arthorplasty: a report of 65 cases. In: Leach RE, Hoaglund FT, Riseborough EJ, eds. Controversies in orthopaedic surgery. Philadelphia: WB Saunders: 382-398
  • Hope PG, Kristinsson KG, Norman P, Elson RA. Deep infection of cemented total hip arthroplasties caused by coagu-lase-negative staphylococci. J Bone Joint Surg [Br] 1989; 71 (5): 851–855.
  • Elson R. Results of primary exchange in infected total hip replacement. Toronto, June 1992. Combined meeting of the orthopaedic Associations of the English-Speaking World, Toronto, June
  • Duncan CP, Masri BA. The role of antibiotic-loaded cement in the treatment of an infection after a hip replace-ment. Instr Course Lect 1995; 44: 305–313.
  • Sanzen L, Carlsson AS, Josefsson G, Lindberg LT. Revision operations on infected total hip arthroplasties. Two-to nine-year follow-up study. Clin Orthop 1988; 229: 165–172.
  • Hunter GA. The results of reinsertion of a total hip prosthesis after sepsis. J Bone Joint Surg [Br] 1979; 61: 422–423.
  • Tenover FC, Gold R, Nelson JP. Implantation of total hip arthroplasty after known deep infection. Orthop Trans 1980; 4: 97.
  • Clerney DL, Amstutz HC. Total hip replacement in the previously septic hip. J Bone Joint Surg [Am] 1983; 65: 1256–1265.
  • Fitzgerald RH. Indirect exchange of the infected hip implant. Orthop Trans 1981; 5: 372.
  • Jupiter JB, Karchmer AW, Lowell JD, Harris WH. Total hip arthroplasty in the treatment of adult hips with cur-rent or quiescent sepsis. J Bone Joint Surg [Am] 1981; 63: 194–200.
  • Salvati EA, Chekofsky KM, Brause BD, Wilson PDJ. Reimplantation in infection: a 12-year experience. Clin Orthop 1982; 170: 62–75.
  • Salvati EA, Callaghan JJ, Brause BD. Prosthetic reim-plantation for salvage of the infected hip. Instr Course Lect 1986; 35: 234–241.
  • Ahlgren SA, Gudmundsson G, Bartholdsson E. Function after removal of a septic total hip prosthesis. A sur-vey of 27 Girdlestone hips. Acta Orthop Scand 1980; 51 (3): 541-545.
  • Clegg J. The results of the pseudarthrosis after removal of an infected total hip prosthesis. J Bone Joint Surg [Br] 1977; 59 (3): 298–301.
  • Weber FA, Lautenbach EE. Revision of infected total hip arthroplasty. Clin Orthop 1986; 211: 108–115.
  • Dirschl DR, Wilson FC. Topical antibiotic irrigation in the prophylaxis of operative wound infections in orthopedic surgery. Orthop Clin North Am 1991; 22 (3): 419–426.
  • Benjamin JB, Volz RC. Efficacy of a topical antibiotic irrigant in decreasing or eliminating bacterial contamination in surgical wounds. Clin Orthop 1984; 184: 114–117.
  • Kantor GS, Osterkamp JA, Dorr LD, Fischer D, Perry J, Conaty JP. Resection arthroplasty following infected total hip replacement arthroplasty. J Arthroplasty 1986; 1 (2): 83–89.
  • Goldman RT, Scuderi GR, Insall JN. 2-stage reimplan-tation for infected total knee replacement. Clin Orthop 1996; 331: 118–124.
  • Alexeeff M, Mahomed N, Morsi E, Garbuz D, Gross A. Structural allograft in two-stage revisions for failed septic hip arthroplasty. J Bone Joint Surg Br 1996; 78 (2): 213–216.
  • Katz RP, Callaghan JJ, Sullivan PM, Johnston RC. Results of cemented femoral revision total hip arthroplasty using improved cementing techniques. Clin Orthop 1995; 319: 178–183.
  • Kavanagh BF, Ilstrup DM, Fitzgerald RHJ. Revision total hip arthroplasty. J Bone Joint Surg [Am] 1985; 67 (4): 517–526.
  • Mulroy WF, Harris WH. Revision total hip arthroplasty with use of so-called second-generation cementing techniques for aseptic loosening of the femoral component. A fifteen-year-average follow-up study. J Bone Joint Surg Am 1996; 78 (3): 325–330.
  • Pellicci PM, Wilson PDJ, Sledge CB, et al. Long-term results of revision total hip replacement. A follow-up report. J Bone Joint Surg [Am] 1985; 67 (4): 513–516.
  • petty W, Spanier S, Shuster JJ. Prevention of infection after total joint replacement. Experiments with a canine model. J Bone Joint Surg [Am] 1988; 70 (4): 536-539.
  • Jerry GJJ, Rand JA, Ilstrup D. Old sepsis prior to total knee arthroplasty. Clin Orthop 1988; 236: 135–140.
  • Lai KA, Shen WJ, Yang CY, Lin RM, Lin CJ, Jou IM. Two-stage cementless revision THR after infection. 5 recur-rences in 40 cases followed 2.5-7 years. Acta Orthop Scand 1996; 67 (4): 325-328.
  • Wang JW, Chen CE. Reimplantation of infected hip arthroplasties using bone allografts. Clin Orthop 1997; 335: 202–210.
  • Buchholz HW, Elson RA, Heinert K. Antibiotic-loaded acrylic cement: current concepts. Clin Orthop 1984; 190: 96–108.
  • Brien WW, Salvati EA, Klein R, Brause B, Stern S. Antibiotic impregnated bone cement in total hip arthroplasty. An in vivo comparison of the elution properties of tobramycin and vancomycin. Clin Orthop 1993; 296: 242–248.
  • Masri BA, Duncan CP, Beauchamp CP. Long-term elu-tion of antibiotics from bone-cement: an in vivo study using the prosthesis of antibiotic-loaded acrylic cement (PROSTA-LAC) system. J Arthroplasty 1998; 13 (3): 331–338.
  • Penner MJ, Masri BA, Duncan CP. Elution characteris-tics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty 1996; 11 (8): 939–944.
  • Wahlig H, Dingeldein E. Antibiotics and bone cements. Experimental and clinical long-term observations. Acta Orthop Scand 1980; 51 (1): 49–56.
  • Heck D, Rosenberg A, Schink-Ascani M, Garbus S, Kiewitt T. Use of antibiotic-impregnated cement during hip and knee arthroplasty in the United States. J Arthroplasty 1995; 10 (4): 470–475.
  • Espehaug B, Engesaeter LB, Vollset SE, Havelin LI, Langeland N. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br 1997; 79 (4): 590-595.
  • Sande MA, Mandell GC. The aminoglycoside (antimi-crobial agents). In: Gilman AG, Goodman LS, Gilman A, eds. The pharmacologic basis of therapeutics. New York: Macmil-lan. 1980: 1174-1175
  • Kahlmeter G. Gentamicin and tobramycin, clinical phar-macokinetics and nephrotocixity: aspects on assay techniques. Scand J Infect Dis 1989; 18 suppl: 12-22.
  • Anglim AM, Klym B, Byers KE, Scheld WM, Farr BM. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus fae-cium. Arch Intern Med 1997; 157 (10): 1132–1136.
  • Shlaes DM, Gerding DN, John JFJ, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997; 18 (4): 275–291.
  • Segreti J, Trenholme GM. Infective endocarditis. Curr Treat Options Cardiovasc Med 1999; 1 (3): 283–290.
  • Rybak MJ, Coyle EA. Vancomycin-resistant enterococ-cus: infectious endocarditis treatment. Curr Infect Dis Rep 1999; 1 (2): 148–152.
  • Recommendations for preventing the spread of van-comycin resistance. Hospital Infection Control Practices Advisory Committee (HICPAC) [published erratum appears in Infect Control Hosp Epidemiol 1995 Sep;16 (9): 498]. Infect Control Hosp Epidemiol 1995; 16 (2): 105–113.
  • Elson RA, Jephcott AE, McGechie DB, Verettas D. Antibiotic-loaded acrylic cement. J Bone Joint Surg [Br] 1977; 59 (2): 200–205.
  • Marks KE, Nelson CL, Lautenschlager EP. Antibiotic-impregnated acrylic bone cement. J Bone Joint Surg [Am] 1976; 58 (3): 358–364.
  • Lautenschlager EP, Jacobs JJ, Marshall GW, Meyer PRJ. Mechanical properties of bone cements containing large doses of antibiotic powders. J Biomed Mater Res 1976; 10 (6): 929–938.
  • Carlsson AK, Lidgren L, Lindberg L. Prophylactic antibiotics against early and late deep infections after total hip replacements. Acta Orthop Scand 1977; 48 (4): 405–410.
  • Josefsson G, Lindberg L, Wiklander B. Systemic antibi-otics and gentamicin-containing bone cement in the prophy-laxis of postoperative infections in total hip arthroplasty. Clin Orthop 1981; 159: 194–200.
  • Abendschein W. Salvage of infected total hip replace-ment: use of antibiotic/PMMA spacer. Orthopedics 1992; 15 (2): 228–229.
  • Hovelius L, Josefsson G. An alternative method for exchange operation of infected arthroplasty. Acta Orthop Scand 1979; 50 (1): 93–96.
  • Harle A. Infection management in total hip replace-ment. Arch Orthop Trauma Surg 1989; 108 (2): 63–71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.